Ron Bentsur, Chairman and CEO of Nuvectis Pharma ($NVCT), made one open market purchase of company shares in the last year, totaling $28,600, with the most recent on November 5, 2025. This ranks 3,484th among 4,983 insiders in our database, where the average purchase is $1.46 million across about 3.3 transactions. Bentsur reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | A | Common Stock | 150000 | $0.00 | 3,675,924.0000 | 21,812,716 | 4.25% | 0.69% |
| Nov. 5, 2025 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 5000 | $5.72 | 3,525,924.0000 | 22,719,057 | 0.14% | 0.02% |
| Jan. 2, 2025 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | A | Common Stock | 250000 | $0.00 | 3,520,924.0000 | 17,113,169 | 7.64% | 1.46% |
| Dec. 24, 2024 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 4500 | $4.65 | 3,270,924.0000 | 17,230,559 | 0.14% | 0.03% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 24000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 45000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 40000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | D | Stock Options (Right to buy) | 30000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Options (Right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2024 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 20000 | $4.92 | 3,266,424.0000 | 17,230,559 | 0.62% | 0.12% |
| May 14, 2024 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 1940 | $6.74 | 3,246,424.0000 | 16,559,335 | 0.06% | 0.01% |
| May 10, 2024 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 2000 | $6.40 | 3,244,484.0000 | 16,559,335 | 0.06% | 0.01% |
| March 20, 2024 | Beyond Air, Inc. | $XAIR | BENTSUR RON | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| March 18, 2024 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 5000 | $10.29 | 3,242,484.0000 | 15,556,655 | 0.15% | 0.03% |
| Oct. 10, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 640 | $11.08 | 3,237,484.0000 | 16,104,446 | 0.02% | 0.00% |
| Oct. 6, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 250 | $11.27 | 3,236,014.0000 | 16,104,446 | 0.01% | 0.00% |
| Oct. 9, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 830 | $11.19 | 3,236,844.0000 | 16,104,446 | 0.03% | 0.01% |
| Oct. 5, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 1400 | $11.09 | 3,235,764.0000 | 16,104,446 | 0.04% | 0.01% |
| Oct. 4, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 1820 | $10.95 | 3,234,364.0000 | 16,104,446 | 0.06% | 0.01% |
| Aug. 16, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 115 | $15.15 | 3,232,544.0000 | 15,178,035 | 0.00% | 0.00% |
| Aug. 15, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 235 | $14.34 | 3,232,429.0000 | 15,178,035 | 0.01% | 0.00% |
| Aug. 11, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 180 | $14.66 | 3,232,194.0000 | 15,178,035 | 0.01% | 0.00% |
| Aug. 8, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 120 | $14.83 | 3,232,014.0000 | 15,178,035 | 0.00% | 0.00% |
| July 21, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 225 | $14.85 | 3,231,894.0000 | 15,178,035 | 0.01% | 0.00% |
| July 20, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 110 | $15.06 | 3,231,669.0000 | 15,178,035 | 0.00% | 0.00% |
| July 19, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 200 | $14.33 | 3,231,559.0000 | 15,178,035 | 0.01% | 0.00% |
| July 14, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 150 | $15.03 | 3,231,359.0000 | 15,178,035 | 0.00% | 0.00% |
| July 7, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 110 | $16.19 | 3,231,209.0000 | 15,178,035 | 0.00% | 0.00% |
| July 6, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 320 | $14.88 | 3,231,099.0000 | 15,178,035 | 0.01% | 0.00% |
| June 26, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 750 | $16.50 | 3,230,779.0000 | 14,724,249 | 0.02% | 0.01% |
| June 21, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 500 | $17.88 | 3,230,029.0000 | 14,724,249 | 0.02% | 0.00% |
| June 8, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 120 | $17.53 | 3,229,529.0000 | 14,724,249 | 0.00% | 0.00% |
| June 7, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 230 | $17.41 | 3,229,409.0000 | 14,724,249 | 0.01% | 0.00% |
| May 31, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 330 | $17.28 | 3,229,179.0000 | 14,724,249 | 0.01% | 0.00% |
| May 24, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 200 | $17.49 | 3,228,849.0000 | 14,724,249 | 0.01% | 0.00% |
| May 16, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 320 | $17.03 | 3,228,649.0000 | 14,724,249 | 0.01% | 0.00% |
| March 23, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 230 | $12.13 | 3,228,329.0000 | 12,657,651 | 0.01% | 0.00% |
| March 21, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 480 | $12.08 | 3,228,099.0000 | 12,657,651 | 0.01% | 0.00% |
| March 14, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 1680 | $10.85 | 3,227,139.0000 | 12,657,651 | 0.05% | 0.01% |
| March 15, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | P | Common Stock | 480 | $10.91 | 3,227,619.0000 | 12,657,651 | 0.01% | 0.00% |
| Jan. 12, 2023 | Nuvectis Pharma, Inc. | $NVCT | BENTSUR RON | Chairman & CEO | A | Common Stock | 210000 | $0.00 | 3,225,459.0000 | 12,657,651 | 6.96% | 1.66% |